Michael Shawn Moran - 31 Jan 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
EVP, Chief Commercial Officer
Signature
/s/ Brian Cahill, Attorney-in-Fact
Issuer symbol
EGRX
Transactions as of
31 Jan 2022
Net transactions value
-$9,647
Form type
4
Filing time
01 Feb 2022, 17:46:48 UTC
Previous filing
11 Jan 2022
Next filing
04 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability $9,647 -210 -0.93% $45.94 22,457 31 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations.